Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

Published on 12 Apr 2024 on GuruFocus.com via Yahoo Finance

Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

Vera Therapeutics Inc (NASDAQ:VERA), a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, has reported an insider sale according to a recent SEC filing. Joseph Young, the company's Senior Vice President of Finance and Chief Accounting Officer, sold 5,714 shares of the company on April 10, 2024. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this SEC Filing.

Warning! GuruFocus has detected 1 Warning Sign with VERA.

Read the rest of the article

NASDAQ.VERA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

News

Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

NASDAQ.VERA price evolution

Want to become a better investor?

Vera Therapeutics' Atacicept Shows Sustained, Substantial Improvement In Kidney...

Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024?

Vera Therapeutics, Inc. (VERA): Among the Best Mid-Cap Healthcare Stocks To Buy...

Vera Therapeutics, Inc.'s (NASDAQ:VERA) high institutional ownership speaks for itself as stock...

Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...

Vera Therapeutics executive sells over $228k in company stock

Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact -...

Vertex Pharma’s takeover of Alpine Immune is a strategic fit: analysts

Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer

Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)